Zinc finger protein ZNF202 structure and function in transcriptional control of HDL metabolism

Current Opinion in Lipidology

Volumn 15, Issue 2, 2004, Pages 199-208

  Schmitz, Gerd ^a   Heimerl, Susanne ^a   Langmann, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

HDL; PPARS; SCAN; SDP1; ZNF202

Indexed keywords

HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZNF202 PROTEIN;

ATHEROSCLEROSIS; GENE FUNCTION; GENE STRUCTURE; GENE TARGETING; LIPID METABOLISM; METABOLIC SYNDROME X; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS, HDL; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 1842557516     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200404000-00013     Document Type: Review

References (95)

1. Kort EN, Ballinger DG, Ding W, et al. Evidence of linkage of familial hypoalphalipoproteinemia to a novel focus on chromosome 11q23. Am J Hum Genet 2000; 66:1845-1856.
2. Monaco C, Helmer CM, Caprini E, et al. Molecular cloning and characterization of ZNF202: a new gene at 11q23.3 encoding testis-specific zinc finger proteins. Genomics 1998; 52:358-362.
3. Wagner S, Hess MA, Ormonde-Hanson P, et al. A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J Biol Chem 2000; 275:15685-15690.
4. Honer C, Chen P, Toth MJ, Schumacher C. Identification of SCAN dimerization domains in four gene families. Biochim Biophys Acta 2001; 1517:441-448.
5. Schumacher C, Wang H, Honer C, et al. The SCAN domain mediates selective oligomerization. J Biol Chem 2000; 275:17173-17179.
6. Margolin JF, Friedman JR, Meyer WK, et al. Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A 1994; 91:4509-1513.
7. Lechner MS, Begg GE, Speicher DW, Rauscher FJ III. Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential. Mol Cell Biol 2000; 20:6449-6465.
8. Porsch-Ozcurumez M, Langmann T, Heimerl S, et al. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux. J Biol Chem 2001; 276:12427-12433.
9. Langmann T, Schumacher C, Morham SG, et al. ZNF202 is inversely regulated with its target genes ABCA1 and apoE during macrophage differentiation and foam cell formation. J Lipid Res 2003; 44:968-977. This study provided the first data on the inverse transcriptional regulation of ZNF202 and its target genes ABCA1 and apoE. Furthermore, the structure of the upstream regulatory region and important promoter elements involving the transcription factor PU.1 are presented
10. Espinas ML, Jimenez-Garcia E, Vaquero A, et al. The N-terminal POZ domain of GAGA mediates the formation of oligomers that bind DNA with high affinity and specificity. J Biol Chem 1999; 274:16461-16469.
11. Babb R, Bowen BR. SDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domain. Biochem J 2003; 370 (Pt 2):719-727. This interesting study identified SDPt as an important transcriptional coregulator of ZNF202 and PPARγ in humans, suggesting an outstanding role of SCAN domain proteins in modulation of transcriptional networks.
12. Castillo G Brun RP, Rosenfield JK, et al. An adipogenic cofactor bound by the differentiation domain of PPARgamma, EMBO J 1999; 18:3676-3687.
13. Chinetti G, Lestavel S, Bocher V, et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCAt pathway. Nat Med 2001; 7:53-58.
14. Albanese V, Biguet NF, Kiefer H, et al. Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 2001; 10:1785-1792.
15. Sharma P, Hingorani A, Jia H, et al. Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension 1998; 32:676-682.
16. Serretti A, Macciardi F, Verga M, et al. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet 1998; 81:127-130.
17. Wei J, Ramchand CN, Hammings GP. Possible association of catecholamine turnover with the polymorphic (TCAT)n repeat in the frst intron of the human tyrosine hydroxylase gene. Life Sci 1997; 61:1341-1347.
18. Zannis VI, Kan HY, Kritis A, et al. Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo. Curr Opin Lipidol 2001; 12:181-207.
19. Prieur X, Coste H, Rodriguez JC. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J Biol Chem 2003; 278:25488-25480.
20. Curtiss LK, Boisvert WA. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 2000; 11:243-251.
21. Laffitte BA, Repa JJ, Joseph SB, et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A 2001; 98:507-512.
22. Mak PA, Kast-Woelbern HR, Anisfeld AM, Edwards PA. Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J Lipid Res 2002; 43:2037-2041. The authors demonstrate a tissue-specific regulation of PLTP and apoE by nuclear hormone receptors.
23. Salero E, Gimenez C, Zafra F. Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene. Biochem J 2003; 370 (Pt 3):979-986.
24. Jiang XC, Bruce C, Mar J, et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999; 103:907-914.
25. Jauhiainen M, Metso J, Pahtman R, et al. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268:4032-4036.
26. Tan KC, Shiu SW, Wong Y. Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus. Eur J Clin Invest 2003; 33:301-306.
27. Tu AY, Albers JJ. DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Biochem Biophys Res Commun 1999; 264:902-807.
28. Tu AY, Nishida HI, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993; 268:23098-23105.
29. Schmitz G, Kaminski WE, Orso E. ABC transporters in cellular lipid trafficking. Curr Opin Lipidol 2000; 11:403-501.
30. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000; 275:28240-28245.
31. Langmann T, Porsch-Ozcurumez M, Heimerl S, et al. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter At promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem 2002; 277:14443-14450. The paper demonstrates sterol-independent transcriptional mechanisms for ABCA1, a key molecule in cellular lipid efflux, involving Sp1, Sp3 and E-box binding factors.
32. Klucken J, Buchler C, Orso E, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci U S A 2000; 97:817-822.
33. Langmann T, Porsch-Orcurumez M, Unkelbach U, et al. Genomic organization and characterization of the promoter of the human ATP-binding cassette transporter-G1 (ABCG1) gene. Biochim Biophys Acta 2000; 1494:175-180.
34. Perret B, Mabile L, Martinez L, et al. Hepatic lipase: structure/ function relationship, synthesis, and regulation. J Lipid Res 2002; 43:1163-1189.
35. Medh JD, Bowen SL, Fry GL, et al. Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro. J Lipid Res 1999; 40:1263-1275.
36. Sensel MG, Legrand-Lorans A, Wang ME, Bensadoun A. Isolation and characterization of clones for the rat hepatic lipace gene upstream regulatory region. Biochim Biophys Acta 1990; 1048:297-302.
37. Zambon A, Deeb SS, Brown BG, et al. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation 2001; 103:792-798.
38. Preiss-Landl K, Zimmermann R, Hammerle G, Zechner R, Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 2002; 13:471-481.
39. Semenkovich CF, Chen SH, Wims M, et al. Lipoprotein lipase and hepatic lipase mRNA tissue specific expression, developmental regulation, and evolution. J Lipid Res 1989; 30:423-431.
40. O'Brien KD, Gordon D, Deeb S, et al. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest 1992; 89:1544-1550.
41. Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem 2001; 276:43018-43024.
42. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996; 15:5336-5348.
43. Schoonjans K, Gelman L, Haby C, et al. Induction of LPL gene expression by sterols in mediated by a sterol regulatory element and is independent of the presence of multiple E boxes. J Mol Biol 2000; 304:323-334.
44. Sartippour MR, Lambert A, Laframboise M, et al. Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. Diabetes 1098; 47:431-438.
45. Santamarina-Fojo S, Lambert G, Hoeg JM, Brewer HB Jr. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2000; 11:267-275.
46. Hoppe KL, Francone OL. Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter. J Lipid Res 1998; 39:969-977.
47. Walkey CJ, Shields DJ, Vance DE. Identification of three novel cDNAs for human phosphatidylethanolamine N-methyltransferase and localization of the human gane on chromosome 17p11.2. Biochim Biophys Acta 1999; 1436:405-412.
48. Shields DJ, Agellon LB, Vance DE. Structure, expression profile and alternative processing of the human phosphatidylethanolamine N-methyltransferase (PEMT) gene. Biochim Biophys Acta 2001; 1532:105-114.
49. Dobrosotskaya IY. Seegmiller AC, Brown MS, et al. Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 2002; 296:879-883. This outstanding study provided detailed data on the influence of different lipids on SREBP processing. Furthermore phosphatidylethanolamine is shown to contol SREBP release from Drosophila cell membranes.
50. Yool DA, Edgar JM, Montague P, Malcolm S. The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet 2000; 12:987-992.
51. Delva L, Bastie JN, Rochette-Egly C, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999; 19:7158-7167.
52. Napoli JL. Retinoic acid biosynthesis and metabolism. FASEB J 1998; 10:993-1001.
53. Astrom A, Pettersson U, Chambon P, Voorhees JJ. Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. J Biol Chem 1994; 269:22334-22339.
54. Dhe-Paganon S, Duda K, Iwamoto M, et al. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 2002; 277:37973-37976. 7
55. Duncan SA, Navas MA, Dufort D, et al. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998; 281:692-69 5.
56. Garuti R, Croce MA, Piccinini L, et al. Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cells. Gene 2002; 283:133-143.
57. Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384:458-460.
58. Bartoov-Shifman R, Hertz R, Wang H, et al. Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha. J Biol Chem 2002; 277:25914-25919. This work demonstrates that in addition to HNF1, HNF4 is able to transactivate the insulin gene promoter, underlying the central role of this transcription factor in diabetes.
59. Wang JC, Stromstedt PE, Sugiyama T, Granner DK. The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 beta (hepatic nuclear factor-3 beta) and HNF4 and the necessity of proper alignment of their cognate binding sites. Mol Endocrinol 1999; 13:604-618.
60. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413:131-138.
61. Bailly A, Spath G, Bender V, Weiss MC. Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell. J Cell Sci 1998; 111 (Pt 16):2411-2421.
62. Morrisey EE, Tang Z, Sigrist K, et al. GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev 1998; 12:3579-3590.
63. Thomas H, Jaschkowitz K, Bulman M, et al. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 2001; 10:2089-2097.
64. Breslin MB, Zhu M, Notkins AL, Lan MS. Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence. Nucleic Acids Res 2002; 30:1038-1045.
65. Zhu M, Breslin MB, Lan MS. Expression of a novel zinc-finger cDNA, IA-1, is associated with rat AR42J cells differentiation into insulin-positive cells. Pancreas 2002; 24:139-145.
66. Breslin MB, Zhu M, Lan MS. NeuroD1/E47 regulates the E-box element of a novel zinc finger transcription factor, IA-1, in developing nervous system. J Biol Chem 2003; 278:38991-38997.
67. Argiles JM, Busquets S, Lopez-Soriano FJ. The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 2002; 293:1145-1152.
68. Boss O, Bachman E, Vidal-Puig A, et al. Role of the beta(3)-adrenergic receptor and/or a putative beta(4)-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-gamma coactivator-1. Biochem Biophys Res Commun 1999; 261:870-876.
69. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995; 333:343-347.
70. Kadowaki H, Yasuda K, Iwamoto K, et al. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215:555-560.
71. Okumura K, Matsui H, Ogawa Y, et al. The polymorphism of the beta3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size. Metabolism 2003; 52:356-361. A linkage between genetic variants of beta3-adrenergic receptor gene and lipid metabolism is provided.
72. Dixon TM, Daniel KW, Farmer SR, Collins S. CCAAT/enhancer-binding protein alpha is required for transcription of the beta 3-adrenergic receptor gene during adipogenesis. J Biol Chemn 2001; 276:722-728.
73. Feve B, Baude B, Krief S, et al. Inhibition by dexamethasone of beta 3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism. J Biol Chem 1992; 267:15909-15915.
74. Krief S, Feve B, Baude B, et al. Transcriptional modulation by n-butyric acid of beta 1-, beta 2-, and beta 3-adrenergic receptor balance in 3T3-F442A adipocytes. J Biol Chem 1994; 269:6664-6670.
75. Zachary I. Vascular endothelial growth factor. Int J Biochem Cell Biol 1998; 30:1169-1174.
76. Bernatchez PN, Tremblay F, Rollin S, et al. Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: Role in cellular migration. J Cell Biochem 2003; 90:719-731.
77. de Vries C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255:989-991.
78. Quinn TP, Peters KG, de Vries C, et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 1903; 90:7533-7537.
79. Xin X, Yang S, Kowalski J, Gerritsen ME. Peroxisome proliferator- activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 1900; 274:9116-9121.
80. Fauconnet S, Lascombe I, Chabannes E, et al. Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator- activated receptors in bladder cancer cells. J Biol Chem 2002; 277:23534-23543.
81. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducibte factor 1. Mol Cell Biol 1996; 16:4604-4613.
82. Schafer G, Cramer T, Suske G, et al. Oxidative stress regulates vascular endothelial growth factor-A gone transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003; 278:8190-8198.
83. Salimath B, Marme D, Finkenzeller G. Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene 2000; 19:3470-3476.
84. Zhang L, Yu D, Hu M, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res 2000; 60:3655-3661.
85. Schwaller B, Meyer M, Schiffmann S. 'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 2002; 1:241-258.
86. Billing-Marczak K, Buzanska L, Winsky L, et al. AP2-like cis element is required tor calretinin gene promoter activity in cells of neuronal phenotype differentiated from multipotent human cell line DEV. Biochim Biophys Acta 2002; 1577:412-420.
87. Baixeras E, Huard B, Miossec C, et al. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med 1992; 176:327-337.
88. Workman CJ, Dugger KJ, Vignali DA. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immunol 2002; 169:5392-5395.
89. Workman CJ, Vignali DA. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 2003; 33:970-979.
90. Andreae S, Piras F, Burdin N, Triebel F. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 2002; 168:3874-3880.
91. Bruniquel D, Borie N, Hannier S, Triebel F. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II. Immunogenetics 1996; 48:116-124.
92. Patwardhan S, Gashler A, Siegel MG, et al. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene 1991; 6:917-928.
93. Tourtellotte WG, Milbrandt J. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat Genet 1998; 20:87-91.
94. Mages HW, Baag R, Steiner B, Kroczek RA. Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A. Mol Cell Biol 1998; 18:7157-7165.
95. Liu D, Jia H, Holmes DI, et al. Vascular endothelial growth factor-regulated gene expression in endothelial cells. KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 2003; 23:2002-2007.